Owner Appetite Assessment
|Treatment success–single-ques>on assessment %*||68.6||44.6||0.0078|
|Treatment success–owner appe>te assessment, %**||56.2||26.8||0.0071|
|Percent change in owner appe>te assessment, mean (±SD)||73.3 (±75.9)||37.6 (±53.9)||0.0125|
|Percent change in body weight, mean (±SD)||1.83 (±2.75)||0.11 (±3.61)||0.0004|
**Treatment success was defined as an increase in total score ≥5 from day 0 to day 3 ± 1 (scoring scale 5-25)
Laboratory Effectiveness Study
ENTYCE treated dogs demonstrated significantly increased food consumption compared to dogs that received placebo
Results demonstrated that ENTYCE-treated dogs had a 61% increase in food consumption vs. reduction of 11% in placebo-treated dogs (P< 0.001).2
Your convenient one-stop source for viewing clinical studies and expert insights.Seek
Use these downloadable tools for identifying inappetence in dogs and how to use ENTYCE.Implement
Browse a series of short videos tolearn about managing inappetence in dogs with chronic medical conditions with ENTYCE.Explore
- Zollers B, Wofford JA, Heinen E, Huebner M, Rhodes L. A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with ReducedAppetite. J Vet Intern Med. 2016;30(6):1851-1857.
- Zollers B, Rhodes L, Heinen E. Capromorelin oral solution increases food consumption and body weight when administered for 4 consecutive days tohealthy adult Beagle dogs in a randomized, masked, placebocontrolled study. BMC Vet Res. 2017; 13:10.